(-0.08%) 5 303.75 points
(-0.09%) 40 107 points
(-0.07%) 18 491 points
(0.54%) $81.79
(-0.70%) $1.706
(0.05%) $2 213.70
(-0.81%) $24.55
(-0.28%) $907.15
(0.32%) $0.926
(0.63%) $10.84
(0.24%) $0.793
(-0.15%) $92.30
Live Chart Being Loaded With Signals
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers...
Stats | |
---|---|
Today's Volume | 39 294.00 |
Average Volume | 3 204.00 |
Market Cap | 101 002 |
EPS | $-0.0658 ( 2023-08-11 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0100 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-11-23 | Greenspan Ira Scott | Sell | 3 000 000 | W Warrants |
2021-11-23 | Lamstein Joshua R | Sell | 3 000 000 | W Warrants |
2021-06-01 | Hopper Paul | Buy | 6 333 | Common Stock |
2020-12-15 | Hopper Paul | Buy | 0 | Common Stock |
2020-12-15 | Hopper Paul | Sell | 0 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 55 transactions |
Buy: 2 180 518 | Sell: 6 965 870 |
Scopus Biopharma Inc. Correlation
10 Most Positive Correlations | |
---|---|
KTTA | 0.932 |
ISPO | 0.915 |
UTME | 0.91 |
SMIT | 0.91 |
MTP | 0.909 |
CREG | 0.908 |
NCBS | 0.906 |
HOL | 0.905 |
NKTX | 0.904 |
SWVL | 0.902 |
10 Most Negative Correlations | |
---|---|
GDNR | -0.933 |
AMYT | -0.924 |
NWLI | -0.913 |
BRAC | -0.911 |
EMLD | -0.91 |
BTWN | -0.91 |
CDZI | -0.909 |
AVAC | -0.909 |
PROF | -0.908 |
EXAS | -0.908 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Scopus Biopharma Inc. Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.550 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.0658 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.0807 |
Q4 | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.0821 |
Financial Reports:
No articles found.
Scopus Biopharma Inc.
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule that is an inverse agonist of the endocannabinoid system/cannabinoid receptor 1, as well as an inhibitor of inducible nitric oxide synthase. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators